XTLB
XTL Biopharmaceuticals
XTLB
XTLB
4 hedge funds and large institutions have $753K invested in XTL Biopharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
4
Holders Change
+3
Holders Change %
+300%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Invesco
Atlanta,
Georgia
|
$692K |
| 2 |
2
Jane Street
New York
|
$57K |
| 3 |
U
3
UBS
Zurich,
Switzerland
|
$2K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Invesco
Atlanta,
Georgia
| $692K | 129,811 | +129,811 | New |
|
|
2
Jane Street
New York
| $57K | 10,693 | +10,693 | New |
|
3
Ameriprise
Minneapolis,
Minnesota
| $2K | 441 | – | – |
|
|
U
4
UBS
Zurich,
Switzerland
| $2K | 400 | +400 | New |
|